Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.36 EUR | +0.84% |
|
+8.43% | -7.22% |
06-24 | Sonovein FDA Pivotal Study Treatments Completed: Theraclion Reaches Key Milestone on Schedule | CI |
06-07 | Theraclion: scientific publication hailed by stock market | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.22% | 17.46M | |
+3.77% | 210B | |
+8.83% | 186B | |
+31.94% | 158B | |
+33.19% | 113B | |
+4.03% | 66.13B | |
+22.41% | 56.25B | |
+1.34% | 49B | |
-5.92% | 38.16B | |
+1.94% | 35.98B |
- Stock Market
- Equities
- ALTHE Stock
- News Theraclion
- Theraclion Names CEO